NuGen Medical Devices Inc. (NGMD.V)
- Previous Close
0.0700 - Open
0.0650 - Bid 0.0650 x --
- Ask 0.0800 x --
- Day's Range
0.0650 - 0.0700 - 52 Week Range
0.0400 - 0.1550 - Volume
169,000 - Avg. Volume
148,341 - Market Cap (intraday)
14.152M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
www.nugenmd.comRecent News: NGMD.V
View MorePerformance Overview: NGMD.V
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NGMD.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NGMD.V
View MoreValuation Measures
Market Cap
14.15M
Enterprise Value
25.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.80
Price/Book (mrq)
--
Enterprise Value/Revenue
24.77
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-32.49%
Return on Equity (ttm)
--
Revenue (ttm)
1.01M
Net Income Avi to Common (ttm)
-5.23M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
6.95M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3M